Updates in the Management of Early Alzheimer’s Disease
Host: Richard S. Isaacson, MD
Guest: Marc E. Agronin, MD
Despite decades of research, there are only a handful of FDA-approved drugs available for patients with Alzheimer’s disease (AD). Fortunately, several promising agents for the treatment of AD are in the late stages of development
Join us as Dr. Richard Isaacson and Dr. Marc Agronin take a deeper dive into the important guidelines and advances surrounding the treatment of Alzheimer’s disease.